Phylogenetic analysis of HIV-1 subtypes and drug resistance profile among treatment-naïve people in Kuwait
Affiliations
Affiliations
- Department of Microbiology, Faculty of Medicine, Kuwait University, Kuwait.
- Infectious Diseases Hospital, Ministry of Health, Kuwait.
- Virology Unit, Mubarak Al-Kabeer Hospital, Ministry of Health, Kuwait.
Abstract
Mutations associated with resistance to antiretroviral therapy are a major cause of failure to treatment, and surveillance for the emergence of HIV resistance became a component of all antiretroviral treatment programs. As transmission of resistant viruses to newly infected persons is possible, we aimed to determine the prevalence of primary mutations associated with antiretroviral resistance among treatment-naïve patients, with respect to HIV subtype. Viral RNA was extracted from plasma samples of 43 treatment-naïve patients. Protease (PR) and reverse transcriptase (RT) regions were amplified and sequenced using the TRUGENE HIV-1 Genotyping Assay. A phylogenetic analysis was performed for HIV subtype assignment. Complete sequence information could be obtained for 35 patients. A total of ten different HIV-1 subtypes and recombinant forms were found in Kuwait with predominance of subtypes B, C, and CRF01_AE. A62V and A98G were non-polymorphic resistance-associated mutations (RAMs) detected in the RT region of two and three patients, respectively. Non-polymorphic mutations associated with resistance to protease inhibitors were not detected. Our results support continuous surveillance of RAMs in newly infected individuals to assess the effectiveness of first-line antiretroviral regimen available in Kuwait.
Keywords: HIV-1; Kuwait; drug resistance; subtypes.
Similar articles
Ariffin TA, Mohamad S, Yusuf WN, Shueb RH.J Infect Dev Ctries. 2014 Aug 13;8(8):1063-7. doi: 10.3855/jidc.4095.PMID: 25116676
de Medeiros RM, Junqueira DM, Matte MC, Barcellos NT, Chies JA, Matos Almeida SE.J Med Virol. 2011 Oct;83(10):1682-8. doi: 10.1002/jmv.22188.PMID: 21837783
Handema R, Terunuma H, Kasolo F, Kasai H, Sichone M, Yamashita A, Deng X, Mulundu G, Ichiyama K, Munkanta M, Yokota T, Wakasugi N, Tezuka F, Yamamoto N, Ito M.AIDS Res Hum Retroviruses. 2003 Feb;19(2):151-60. doi: 10.1089/088922203762688667.PMID: 12643279
Rationale and uses of a public HIV drug-resistance database.
Shafer RW.J Infect Dis. 2006 Sep 15;194 Suppl 1(Suppl 1):S51-8. doi: 10.1086/505356.PMID: 16921473 Free PMC article. Review.
Variability in the PR and RT genes of HIV-1 isolated from recently infected subjects.
Turner D, Roldan A, Brenner B, Moisi D, Routy JP, Wainberg MA.Antivir Chem Chemother. 2004 Sep;15(5):255-9. doi: 10.1177/095632020401500504.PMID: 15535047 Review.
Cited by
Genetic clustering analysis for HIV infection among MSM in Nigeria: implications for intervention.
Li Y, Liu H, Ramadhani HO, Ndembi N, Crowell TA, Kijak G, Robb ML, Ake JA, Kokogho A, Nowak RG, Gaydos C, Baral SD, Volz E, Tovanabutra S, Charurat M; TRUST/RV368 Study Group.AIDS. 2020 Feb 1;34(2):227-236. doi: 10.1097/QAD.0000000000002409.PMID: 31634185 Free PMC article.
Drug Resistance-Associated Mutations in Antiretroviral Treatment-Experienced Patients in Kuwait.
Chehadeh W, Albaksami O, John SE, Al-Nakib W.Med Princ Pract. 2018;27(2):152-157. doi: 10.1159/000488108. Epub 2018 Mar 5.PMID: 29506011 Free PMC article.
HIV Responses in Arab States on the Southern Persian Gulf Border: The First Review.
Moradi A, Alammehrjerdi Z, Daneshmand R, Amini-Lari M, Zarghami M, Dolan K.Iran J Psychiatry Behav Sci. 2016 Aug 7;10(3):e5392. doi: 10.17795/ijpbs-5392. eCollection 2016 Sep.PMID: 27822284 Free PMC article. Review.